American adults who haven’t yet gotten vaccinated against COVID-19 may soon get another choice, as advisers to the Food and Drug Administration on Tuesday backed a more traditional type of shot.
Next, the FDA must decide whether to authorize the protein vaccine made by latecomer Novavax as the nation’s fourth coronavirus shot for adults. It’s made with more conventional technology than today’s dominant Pfizer and Moderna shots and the lesser-used Johnson & Johnson option.
“We do have a problem with vaccine uptake that is very serious in the United States,” Marks said. “Anything we can do to get people more comfortable to accept these potentially life-saving products is something that we feel we are compelled to do.”Nor is it clear how widely a Novavax vaccine would be used, at least right away. Only about 27 million U.S. adults remain unvaccinated, according to the Centers for Disease Control and Prevention.
But the FDA is considering two adult doses for now, when other COVID-19 vaccines have needed a third dose, he said. Novavax chief medical officer Dr. Filip Dubovsky said tests of a booster dose revved up virus-fighting antibodies that could tackle the omicron mutant, data that FDA will have to consider later.
COVID-19 vaccines are coming under close scrutiny for the possibility of heart inflammation after the Pfizer and Moderna shots were linked to that rare risk.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Orange County man to plead guilty to $5-million COVID-19 relief loan scamRaghavender Reddy Budamala reportedly used the loans to purchase a $1.2 million 'investment property' in Eagle Rock, a nearly $600,000 property in Malibu and a 'personal residence' in Irvine.
Weiterlesen »
We Can't Keep Getting The Same Formula in COVID-19 Booster Shots, Says ImmunologistBeing up to date on COVID-19 vaccines means having had three or four doses of the same shot at this point. Current boosters are the same formulations as the first authorized shots, based on the original strain of the coronavirus that emerged in late
Weiterlesen »
If you’re still waiting for herd immunity for COVID-19, it's time to move on: ExpertsVaccine scientists and public health experts said herd immunity isn't realistic for COVID-19 because of what we've learned about the virus itself.
Weiterlesen »
Why Variants Keep Covid-19 Cases Simmering in the U.S.A look at some of the Covid-19 data underlying Omicron’s recent spread suggests that an increasing share of Americans have some immunity against SARS-Cov-2, but the virus’s latest subvariant can sidestep our defenses.
Weiterlesen »
COVID-19 infection may not be disability, says San Diego federal judgeAs a Hertz management associate in National City, Michelle Roman’s responsibilities included screening employees for COVID-19 symptoms.
Weiterlesen »
Millions of COVID-19 Vaccines WastedMillions of COVID vaccines doses have been wasted in the United States according to data from the Centers for Disease Control and Prevention.
Weiterlesen »